Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1534099

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1534099

Bromhidrosis Disease Treatment

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Bromhidrosis Disease Treatment Market to Reach US$1.2 Billion by 2030

The global market for Bromhidrosis Disease Treatment estimated at US$756.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Apocrine Body Odor Treatment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$742.8 Million by the end of the analysis period. Growth in the Eccrine Body Odor Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.0 Million While China is Forecast to Grow at 11.1% CAGR

The Bromhidrosis Disease Treatment market in the U.S. is estimated at US$206.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$264.6 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Bromhidrosis Disease Treatment Market - Key Drivers and Trends Summarized

Bromhidrosis, commonly known as body odor, is a medical condition characterized by excessive and offensive body odor caused by bacterial decomposition of sweat. This condition primarily affects the apocrine sweat glands found in areas such as the armpits and groin. Bromhidrosis can be classified into two types: apocrine and eccrine. Apocrine bromhidrosis is associated with the bacterial breakdown of sweat, while eccrine bromhidrosis is linked to the decomposition of sweat from the eccrine glands on the skin's surface. Treatment for bromhidrosis aims to reduce sweat production, minimize bacterial activity, and manage the odor effectively.

The treatment landscape for bromhidrosis has evolved considerably, incorporating both medical and non-medical approaches. Traditional treatments include the use of topical antiperspirants and deodorants that contain aluminum chloride to reduce sweat and mask the odor. For more severe cases, physicians may prescribe antibiotics to address bacterial infections or recommend antiseptic washes to reduce bacterial load on the skin. Additionally, treatments such as botulinum toxin (Botox) injections have gained popularity for their ability to temporarily block nerve signals responsible for sweating. Surgical options, including the removal of sweat glands and sympathectomy, offer more permanent solutions for severe cases. Recent advancements also include laser treatments and microwave thermolysis, which target and destroy overactive sweat glands, providing long-term relief from symptoms.

The growth in the bromhidrosis treatment market is driven by several factors. Firstly, the increasing awareness and social stigma associated with body odor have led more individuals to seek medical treatment, boosting demand for effective therapies. Secondly, advancements in dermatological research and technology have expanded treatment options, making them more accessible and efficient. Additionally, the rise in disposable incomes and improved healthcare infrastructure, particularly in developing regions, has facilitated greater access to both non-invasive and surgical treatments. The growth of e-commerce and telemedicine platforms has also made it easier for patients to access specialized treatments and consultations. Furthermore, the aging population, which is more prone to sweat-related issues, has increased the need for advanced bromhidrosis treatments. Lastly, strategic marketing efforts by pharmaceutical and cosmetic companies to promote awareness and the benefits of their products have played a crucial role in driving market expansion.

Select Competitors (Total 86 Featured) -

  • Avanor Healthcare Ltd
  • Cantabria Labs
  • Clutch, Inc. (DBA Carpe)
  • Ducray Dermatological Laboratories
  • Galderma SA
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • No More Sweat
  • Pampered Skin Care, LLC
  • Salve Pharmaceuticals Pvt. Ltd.
  • Seaford Pharmaceuticals Inc.
  • The Polar Company B.V.
Show more
Product Code: MCP26610

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bromhidrosis Disease Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Bromhidrosis and Its Impact on Quality of Life Drives Demand for Treatments
    • Advancements in Dermatological Treatments Enhance Efficacy and Patient Satisfaction
    • Growing Acceptance of Cosmetic and Aesthetic Procedures Expands Market Opportunities
    • Expansion of Dermatology Clinics and Specialty Centers Increases Market Reach
    • Development of Minimally Invasive and Non-Invasive Treatment Options Attracts Patients
    • Increasing Use of Laser and Radiofrequency Therapies in Bromhidrosis Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bromhidrosis Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Apocrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Eccrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • JAPAN
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CHINA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • EUROPE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • FRANCE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • GERMANY
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • INDIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AFRICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!